Clinical issue
Endogenous stem cells are important in the normal physiology of tissues that undergo constant regeneration, such as hematopoietic cells or those lining the gastrointestinal tract. The enhanced proliferative capacity of stem cells is necessary for the regeneration and healing of damaged tissue, but can also lead to cancer. The carcinogenic potential of stem cells is a significant limitation for their potential use in treating disease. Understanding the mechanisms and signaling pathways that allow stem cells to serve in a controlled regenerative capacity is necessary before their safe therapeutic potential can be realized.
The PTEN protein is a key regulator of cell proliferation, differentiation and motility that is frequently mutated in cancer. PTEN exerts its influence on cellular functions by suppressing the PI3-kinase (PI3K) and AKT pathways. In normal cells, PTEN balances PI3-kinase and AKT activities that otherwise would contribute to the genesis of malignant cancer cells.
Results
Here the planarian is used as a model organism for studying PTEN in stem cells for tissue regeneration. Planarians contain large numbers of adult stem cells (neoblasts) that constantly renew and differentiate into all known planarian cell types.
In the planarian, Schmidtea mediterranea, the authors identify two orthologues to the human PTEN gene, which they name Smed-PTEN-1 and Smed-PTEN-2. They find the genes expressed in many cell types, including the planarian stem cells. Reduced expression of Smed-PTEN-1 and Smed-PTEN-2 encoded proteins using RNAi resulted in abnormal growths, dramatic anatomical changes and the eventual demise of the organism. As in mammals, administration of the drug rapamycin to RNAi-treated worms prevents all of these abnormalities and the death of the animal.
Implications and future directions
An important finding here is the extent of evolutionary conservation of the PTEN pathway that allows researchers to use planaria as a model organism for stem cell biology. This work demonstrates the fundamental importance of PTEN in cellular proliferation and differentiation processes. Work on the PTEN pathway in this system will advance our understanding of the mechanisms regulating proliferation, migration and motility that are likely operating in the emergence of human cancers. It also expands opportunities to understand the relationship between pathways that similarly regulate cancer growth and stem cell potential.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Professor Elizabeth Patton appointed as DMM’s next Editor-in-Chief
We are pleased to announce that The Company of Biologists directors have appointed Professor Elizabeth Patton as DMM's new Editor-in-Chief. As Paresh Vyas writes in his Editorial, Liz ‘brings vitality and a passion for the remit of DMM, and is deeply embedded in the community.’
Did you know DMM Conference Travel Grants can be used for online meetings?
With travel restrictions still in place, we want to continue supporting early-career researchers in their careers. DMM’s Conference Travel Grants can now be used to attend virtual and online scientific meetings, workshops, conferences and training courses.
The current application round closes on 8 February 2021 – find out more.
Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart
Research from Silke Sperling and colleagues uses Drosophila to identify MYOM2 as a candidate gene in congenital heart malformations in this issue’s Editor’s choice.
C. elegans as a disease model
A new Research article from Doyle et al., models spinal muscular atrophy in C. elegans to show that that targeting therapies to muscle cells is more effective than neuronal delivery. Find more research using C. elegans as a disease model in our latest subject collection.
Call for papers – The RAS Pathway: Diseases, Therapeutics and Beyond
Our upcoming special issue is now welcoming submissions until 1 April 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on the targeting the RAS pathway. Find out more about the issue and how to submit your manuscript.
Interview – Kim Landry-Truchon and Nicolas Houde
In an interview, first authors Kim Landry-Truchon and Nicolas Houde discuss their mouse model of the early stages of pleuropulmonary blastoma, reflecting on the implications of their work and the future of their field.